Holen Sie sich die Stockscreener-App
122.36
1.53%
1.49
Schlusskurs vom Vortag:
$120.87
Offen:
$119.29
24-Stunden-Volumen:
303.21K
Relative Volume:
0.45
Marktkapitalisierung:
$3.52B
Einnahmen:
$267.23M
Nettoeinkommen (Verlust:
$-83.50M
KGV:
-39.34
EPS:
-3.11
Netto-Cashflow:
$-59.99M
1W Leistung:
+1.62%
1M Leistung:
-0.99%
6M Leistung:
+21.46%
1J Leistung:
+105.39%
1-Tages-Spanne:
$115.00
$124.20
1-Wochen-Bereich:
$115.00
$132.00
52-Wochen-Spanne:
$54.14
$136.00
Genedx Holdings Corp Stock (WGS) Company Profile
Firmenname
Genedx Holdings Corp
Sektor
Branche
Telefon
888-729-1206
Adresse
333 LUDLOW STREET, STAMFORD
Vergleichen Sie WGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
122.53 | 3.47B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
524.91 | 198.09B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
206.25 | 146.89B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
635.71 | 50.67B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.11 | 39.19B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.02 | 34.64B | 15.70B | 1.24B | 2.01B | 6.9036 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Eingeleitet | Piper Sandler | Overweight |
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-05-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-10 | Eingeleitet | Craig Hallum | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
Alle ansehen
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
Dr. Mimi Lee named Chief Precision Medicine Officer at GeneDx to lead genomics-driven lifelong health - Stock Titan
Is GeneDx Holdings Corp. Equity Warrant stock attractive for hedge fundsQuarterly Trade Report & Proven Capital Preservation Methods - newser.com
Using data filters to optimize entry into GeneDx Holdings Corp. Equity WarrantGlobal Markets & Daily Chart Pattern Signal Reports - newser.com
Analyzing GeneDx Holdings Corp. with risk reward ratio chartsQuarterly Profit Review & Low Risk Entry Point Guides - newser.com
Is GeneDx Holdings Corp. stock a safe haven assetEarnings Trend Report & Weekly High Return Forecasts - newser.com
Market reaction to GeneDx Holdings Corp.’s recent newsWeekly Stock Recap & AI Powered Trade Plan Recommendations - newser.com
Will GeneDx Holdings Corp. stock maintain growth storyJuly 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Heatmap analysis for GeneDx Holdings Corp. and competitors2025 Market Sentiment & Expert Verified Movement Alerts - newser.com
Is GeneDx Holdings Corp. Equity Warrant still worth holding after the dipQuarterly Portfolio Report & Verified Momentum Watchlists - newser.com
Price action breakdown for GeneDx Holdings Corp.Quarterly Portfolio Summary & Expert Curated Trade Setup Alerts - newser.com
GeneDx Holdings Corp. stock daily chart insights2025 Valuation Update & Long Hold Capital Preservation Tips - newser.com
What indicators show strength in GeneDx Holdings Corp.Sell Signal & Reliable Price Action Trade Plans - newser.com
Can GeneDx Holdings Corp. stock deliver surprise earnings beat2025 EndofYear Setup & Technical Pattern Based Signals - newser.com
Developing predictive dashboards with GeneDx Holdings Corp. dataWeekly Stock Report & High Accuracy Trade Alerts - newser.com
100,000 Newborns Goal — GeneDx Joins Florida’s First State‑Backed Genomic Newborn Screening Pilot - Stock Titan
What data driven models say about GeneDx Holdings Corp.’s futureQuarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
Legal Advantage Investments Inc. Boosts Holdings in GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx Holdings Corp. Experiences Evaluation Revision Amid Strong Market Performance and Dynamics - Markets Mojo
Is it time to cut losses on GeneDx Holdings Corp.2025 Performance Recap & Consistent Income Trade Ideas - newser.com
Technical signs of recovery in GeneDx Holdings Corp. Equity Warrant2025 Price Momentum & Weekly Setup with ROI Potential - newser.com
Can volume confirm reversal in GeneDx Holdings Corp. Equity Warrant2025 Earnings Impact & Risk Controlled Daily Trade Plans - newser.com
Using Python tools to backtest GeneDx Holdings Corp. strategiesQuarterly Investment Review & Real-Time Market Sentiment Alerts - newser.com
Technical analysis overview for GeneDx Holdings Corp. stock2025 Big Picture & Accurate Entry and Exit Point Alerts - newser.com
Using RSI to spot recovery in GeneDx Holdings Corp.Market Risk Summary & Capital Protection Trade Alerts - newser.com
Top chart patterns to watch in GeneDx Holdings Corp.2025 Institutional Moves & Growth Focused Entry Point Reports - newser.com
GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics Annual Meeting - MarketScreener
Genedx to launch autism partnership program to expand access to exome and genome testing - MarketScreener
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program - Yahoo Finance
What data driven models say about GeneDx Holdings Corp. Equity Warrant’s futureJuly 2025 Decliners & Community Consensus Picks - newser.com
Will GeneDx Holdings Corp. rebound enough to break evenDip Buying & Reliable Entry Point Alerts - newser.com
How to escape a deep drawdown in GeneDx Holdings Corp.Rate Hike & High Yield Equity Trading Tips - newser.com
GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting - BioSpace
GeneDx's (WGS) Sell (D) Rating Reaffirmed at Weiss Ratings - MarketBeat
GeneDx Holdings Corp. $WGS Stake Trimmed by Gagnon Securities LLC - MarketBeat
GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025 - MarketScreener
Q3 2025 Results: GeneDx to Release Financials Before Market Open; Investor Webcast and Conference Call - Stock Titan
Slow Capital Inc. Makes New Investment in GeneDx Holdings Corp. $WGS - MarketBeat
How to integrate GeneDx Holdings Corp. Equity Warrant into portfolio analysis tools2025 Price Momentum & Expert Approved Trade Ideas - newser.com
Is GeneDx Holdings Corp. stock ready for breakoutIPO Watch & Reliable Intraday Trade Plans - newser.com
Tools to monitor GeneDx Holdings Corp. recovery probability2025 Fundamental Recap & Capital Protection Trade Alerts - newser.com
Assessing GeneDx (WGS) Valuation Following BEACONS Launch and NIH-Backed Expansion in Newborn Genomics - simplywall.st
Evaluating GeneDx Holdings Corp. Equity Warrant with trendline analysisMarket Activity Recap & Community Verified Watchlist Alerts - newser.com
Is GeneDx Holdings Corp. Equity Warrant stock positioned for long term growthOptions Play & Reliable Entry Point Trade Alerts - newser.com
What machine learning models say about GeneDx Holdings Corp. Equity WarrantQuarterly Performance Summary & Accurate Technical Buy Alerts - newser.com
Detecting price anomalies in GeneDx Holdings Corp. with AIWeekly Risk Report & Verified Entry Point Signals - newser.com
Finanzdaten der Genedx Holdings Corp-Aktie (WGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Genedx Holdings Corp-Aktie (WGS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 30 '25 |
Option Exercise |
32.67 |
1,246 |
40,707 |
10,001 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 30 '25 |
Sale |
108.38 |
6,609 |
716,261 |
3,392 |
0.61%
1.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):